API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/pharma/no-sweat-dermatology-drugmaker-botanix-fda-approval-hyperhidrosis-gel-sofdra
https://www.troutman.com/insights/troutman-pepper-advises-clinical-dermatology-company-botanix-pharmaceuticals-in-acquisition-of-sofpironium-bromide.html
https://www.globenewswire.com/news-release/2021/08/16/2281087/0/en/Brickell-Biotech-Announces-Final-Patient-Completed-Second-U-S-Phase-3-Pivotal-Clinical-Study-of-Sofpironium-Bromide-Gel-15-for-the-Treatment-of-Primary-Axillary-Hyperhidrosis.html
https://www.globenewswire.com/news-release/2021/06/29/2255171/0/en/Brickell-Biotech-Announces-Final-Patient-Completed-in-First-U-S-Phase-3-Pivotal-Clinical-Study-and-Patient-Enrollment-Completed-in-Second-U-S-Phase-3-Pivotal-Clinical-Study-of-Sofp.html
https://www.globenewswire.com/news-release/2020/11/18/2129056/0/en/Brickell-Biotech-Announces-Launch-Date-for-Sofpironium-Bromide-Gel-5-ECCLOCK-in-Japan-by-its-Development-Partner-Kaken-Pharmaceutical.html
https://seekingalpha.com/pr/18020127-brickell-biotech-announces-approval-of-sofpironium-bromide-gel-5-in-japan-for-treatment-of
https://www.biospace.com/article/releases/brickell-biotech-announces-issuance-of-new-composition-of-matter-patent-on-sofpironium-bromide-by-the-japanese-patent-office/
https://www.globenewswire.com/news-release/2020/03/04/1994958/0/en/Brickell-Biotech-Announces-Late-Breaking-Oral-Presentation-at-2020-American-Academy-of-Dermatology-Annual-Meeting-by-its-Asian-Partner-Kaken-Pharmaceutical-for-Sofpironium-Bromide.html
https://www.globenewswire.com/news-release/2020/02/20/1987666/0/en/Brickell-Biotech-Announces-Publication-of-its-U-S-Phase-2b-Study-Results-for-Sofpironium-Bromide-in-Patients-with-Primary-Axillary-Hyperhidrosis-in-the-Journal-of-the-American-Acad.html
https://www.globenewswire.com/news-release/2020/01/10/1969125/0/en/Brickell-Bio-s-Development-Partner-Kaken-Pharmaceutical-Submits-New-Drug-Application-for-Sofpironium-Bromide-in-Japan-for-Primary-Axillary-Hyperhidrosis.html
https://endpts.com/vical-finds-way-out-of-rd-woes-via-reverse-merger-with-dermatology-biotech-brickell/